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ABSTRACT 
Objective: The objective of this research work was to develop a transdermal drug delivery system containing atenolol with different ratios of 
hydrophilic and hydrophobic polymeric combinations, using solvent evaporation technique and to examine the effect of hydrophilicity and 
hydrophobicity of polymers on the physicochemical and drug release properties of transdermal patches. 
Methods: Solvent casting method has been used to formulate transdermal patches. Hydroxypropyl methylcellulose (HPMC), Polyvinylpyrrolidone 
(PVP), Ethylcellulose (EC) in different combination ratios were used as the polymer. Propylene glycol was used as a plasticizer. Permeation 
enhancers such as span 80 were used to enhance permeation through the skin. In vitro diffusion study was carried out by franz diffusion cell using 
egg membrane as a semi-permeable membrane for diffusion. 
Results: Result showed that the thickness of the all batch of patches varied from 0.32 to 0.39 mm with uniformity of thickness in each formulation. 
Formulations F1 to F3 had high moisture content varied from 2.07±0.09 to 2.56±0.15 and high moisture uptake value varied from 3.21±0.35 to 
4.09±0.38, due to a higher concentration of hydrophilic polymers. Drug content of all batches was ranged between 85.92±1.32 to 95.71±1.42. 
Folding endurance values off all batches were more than 75. Formulation batches F1 to F3 showed higher cumulative drug release varied from 
61.34% to 68.11% as compared to formulation batches F4 to F6.  
Conclusion: Higher proportion of hydrophilic polymer in the formulation of transdermal patches, gives higher percentage drug release from 
prepared patches. The finding of the study indicates that hydrophilicity and hydrophobicity of polymer effects the physicochemical and drug release 
properties of transdermal patches and an optimum proportion of hydrophilic and hydrophobic polymer is required for the preparation of effective 
transdermal patches.  
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Transdermal drug delivery system (TDDS) is a promising approach in 
novel drug delivery systems [1]. Transdermal system delivers the 
drugs for the systemic effects at a controlled rate for an extended 
period [2]. It is an effective approach for systemic delivery of drugs 
which have low absorption, short half-lives, and high first-pass 
metabolism [3-4]. Transdermal system provides steady absorption of 
the drug over a long period of time with the facility of immediate 
withdrawal of the treatment if necessary [5-6]. It also reduces the 
dosing frequency and patient variability [7-8]. Transdermal drug 
delivery system consists of a patch that contains drug substance and 
pressed on to skin. Transdermal patches are non-invasive, convenient, 
painless mode of drug administration and can avoid gastrointestinal 
toxicity [9]. In this study, we attempt to formulate the transdermal 
patches of atenolol. Atenolol is a β1-receptor selective antagonist, used in 
treating hypertension, angina, heart failure, and myocardial infarction; 
chemically, it is 4-(2-hydroxyl-3-isopropylaminopropoxy) phenyl-
acetamide. Atenolol has slight water solubility, half-lives of 6-7 h. and 
incomplete absorption from the gastrointestinal tract (GIT) [10]. 
Selection of polymers are important for the formulation of TDDS. 
Polymers have the film forming capacity. When a solution of the 
polymer in a suitable solvent, spreads on a flat surface and allow to 
evaporate then a thin film of polymer is left behind. Similarly, if the 
drug is incorporated in polymer-solvent then drug molecules are 
dispersed in the polymer film and forms the drug-loaded films. 
Hence drug release entirely depends on polymer [11].  
Nature and type of polymers effects the physicochemical and drug 
release properties of transdermal patches. Investigation of the effects 
of hydrophilic and hydrophobic nature of the polymer, on 
physicochemical and drug release properties of transdermal patches, 
is crucial for the optimizing drug release characteristics of transdermal 
patches. The aim of this study was to develop a transdermal 
therapeutic system containing atenolol with different ratios of 
hydrophilic and hydrophobic polymeric combinations, using solvent 
evaporation technique and to examine the effect of hydrophilicity and 
hydrophobicity of polymers on the physicochemical and drug release 
properties of transdermal patches as well as to optimizing the 
proportion of hydrophilic and hydrophobic polymer for providing 
better control on drug release characteristics in transdermal patches. 
MATERIALS AND METHODS 
Materials 
Atenolol, hydroxypropyl methylcellulose (HPMC), polyvinyl-
pyrrolidone (PVP), ethyl cellulose (EC) was gift sample from 
molecular lab Ahmadabad. Propylene glycol and span 80 were of 
laboratory grade. Franz diffusion cell (Ponmani and Co, Coimbatore), 
magnetic stirrer (Remi equipment Ltd., Vasai), pH meter (Hanna 
Instruments, Italy), ultra-violet/visible (UV/VIS) spectrophotometer 
(Shimadzu, Indore), fourier-transform infrared (FTIR) spectro-
meters (Brukar optics. Germany) were also used. 
Methods 
Preparation of calibration curve of atenolol 
The calibration curve was prepared with phosphate buffer pH 7.4 by 
measuring the absorbance at 275 nm. Calibration curve prepared by 
taking absorbance of five serial dilutions of stoke solution on UV/VIS 
spectrophotometer and plotting the graph between absorbance 
versus concentration of the drug. 
Compatibility study 
Compatibility of the drug with polymer mixture was tested on 
Fourier transform infrared spectrometer (FTIR).  
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Preparation of transdermal patches of atenolol  
Matrix patches were prepared by a solvent casting method. Matrix 
patches of varying polymer and composition were prepared in 
water/methanol (1:1) mixture according to table 1. Propylene glycol 
20% w/w of dry weight of the polymer was used as a plasticizer. 
Span 80 was used as a permeation enhancer. Drug was dissolved 
and mixed in the polymer solution and stirred until a clear solution 
obtained. Then the solution was poured into a transdermal mold and 
dried in a desiccator at room temperature. 
 
Table 1: Fabrication of transdermal patches of atenolol 
Ingredient  F1 F2 F3 F4 F5 F6 
Drug (%w/w) 30 30 30 30 30 30 
HPMC (%w/w) 80 70 60 80 70 60 
PVP (%w/w) 20 30 40 - - - 
EC (%w/w) - - - 20 30 40 
Span 80 (%w/w) 10% of dry weight of polymer 
Propylene glycol (%w/w) 20% of dry weight of polymer 
HPMC-Hydroxy propyl methyl cellulose, PVP-Polyvinylpyrrolidone, EC-Ethyl cellulose 
 
Evaluation of transdermal patches 
The thickness of the patch 
Thickness of the films was measured at different places of patches 
by using varnier caliper and an average of five readings was taken. 
Percentage of moisture content 
High concentration of hydrophilic polymer in formulation increases 
the moisture content of patches. So, for testing of moisture content, 
the prepared films were weighed separately and put in a desiccator 
containing calcium chloride at room temperature for 24 h. At 
specified intervals, the films were weighed continuously until they 
showed a constant weight. The percentage (%) moisture content 
was calculated using following formula [12]. 
 
Percentage of moisture uptake  
Percentage of moisture uptake study was also done to check the 
effect of hydrophilic polymer on moisture uptake capacity of 
patches. For determining percentage of moisture uptake, the 
prepared films were weighed separately and put in a desiccator with 
silica gel for 24 h and then were taken outweighed and exposed to 
84% relative humidity using saturated solution of potassium 
chloride in a desiccator until a constant weight was achieved. 
Percentage moisture uptake was calculated as given below [12]. 
 
Test for drug content 
An accurately weighed portion of film (about 100 mg) was dissolved 
in 100 ml volumetric flask containing phosphate buffer (pH 7.4) and 
then the flask was sonicated for 8 h. After sonication, the solution 
was then filtered using a 0.45 μm filter and the drug content was 
analyzed at 275 nm by UV spectrophotometer [13]. 
Folding endurance 
Folding endurance value expresses the folding capacity of the films 
subjected to frequent extreme conditions of folding. Folding 
endurance was determined by repeatedly folding the film at the 
same place until it breaks. The number of times the films could be 
folded at the same place without breaking was folding endurance 
value [14]. 
In vitro diffusion studies 
For in vitro diffusion study, franz diffusion cell was used. The franz 
diffusion cell contains donor and receptor compartment. Egg 
membrane was used as semi-permeable membrane for diffusion 
and it was mounted between donor and receptor compartment. A 
weighed amount of transdermal patch was placed on one side of 
the membrane. Phosphate buffer of pH 7.4 was filled in receptor 
compartment. To maintain the temperature at 37±0.5 ° C, water 
jacket surrounded the receptor compartment. Fluid in receptor 
compartment was stirred continuously by magnetic beads. At 
specific intervals of time, sample was withdrawn from the 
receptor compartment and the same volume of phosphate buffer 
pH 7.4 was added to receptor compartment to maintain sink 
conditions. The samples were analyzed at 275 nm UV-
spectrophotometrically [15]. 
RESULTS AND DISCUSSION 
Calibration curve of atenolol 
The calibration curve was prepared with phosphate buffer pH 7.4. 
The coefficient of determination (R2) value was found to be 0.9879. 
Calibration curve data of atenolol are showed in table 2. 
 
 
Fig. 1: Standard graph of atenolol in phosphate buffer pH 7.4 
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Table 2: Calibration curve data of atenolol 
S. No. Concentration (µg/ml) Absorbance 
1.  10 0.132 
2.  20 0.213 
3.  30 0.386 
4.  40 0.554 
5.  50 0.667 
 
Compatibility study 
The drug was identified and compatibility was confirmed by FTIR 
spectrum from fig. 2, 3, and 4. From FTIR spectra, it was revealed 
that there is no interaction between the drug and polymer mixture 
(HPMC, PVP, and EC). 
The thickness of the patch 
The thickness of all batch of the patches varied from 0.32±0.02to 
0.39±0.01 millimetre (mm). The values obtained for all the 
formulations are given in the table 3. The low (standard deviation) 
SD values in the patches thickness measurements ensured 
uniformity of thickness in each formulation. 
Percentage moisture content 
Higher moisture content can cause the degradation of the patch. 
Percentage moisture content of transdermal patches was found 
within criteria. Formulations F1 to F3 had high moisture content due 
to a higher concentration of hydrophilic polymers. Kaur et al. [16] 
also founded a similar result with a higher concentration of 
hydrophilic polymers in patches. Percentage moisture content value 
of all formulation batches have given in table 4. 
  
 
Fig. 2: IR spectrum of atenolol 
 
 
Fig. 3: IR spectrum of atenolol+(HPMC+PVP mixture) 
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Fig. 4: IR spectrum of atenolol+(HPMC+ECmixture) 
 
Table 3: Thickness of the patches 
S. No./Code F1(mm) F2(mm) F3(mm) F4(mm) F5(mm) F6(mm) 
1 0.33 0.34 0.30 0.39 0.37 0.40 
2 0.37 0.32 0.32 0.38 0.36 0.37 
3 0.30 0.39 0.30 0.32 0.32 0.39 
4 0.31 0.31 0.33 0.40 0.36 0.38 
5 0.34 0.29 0.36 0.36 0.40 0.40 
mean±SD 0.33±0.03 0.33±0.04 0.32±0.02 0.37±0.03 0.36±0.03 0.39±0.01 
mean±SD, n=5, SD-Standard Deviation. 
 
Table 4: Moisture content of patches 
S. No. Formulation code % Moisture content (mean±SD) 
1.  F1 2.10±0.16 
2.  F2 2.07±0.09 
3.  F3 2.56±0.15 
4.  F4 1.58±0.10 
5.  F5 1.37±0.11 
6.  F6 1.13±0.08 
mean±SD, n=3, SD-Standard Deviation. 
 
Percentage moisture uptake 
Formulations F1 to F3 had higher moisture uptake as compare to 
other batches due to higher concentration of hydrophilic 
polymers. Hydrophilic polymers absorb moisture faster and to a 
greater extent than the hydrophobic polymers thus formulation 
batches F1 to F3 gave high moisture uptake value. Sethi et al. [17] 
in their research also got similar results with a hydrophilic 
polymer. Percentage moisture uptake value of all formulation 
batches have given in table 5. 
 
Table 5: Moisture uptake of patches 
S. No. Formulation code % Moisture uptake (mean±SD) 
1 F1 3.21±0.35 
2 F2 3.34±0.30 
3 F3 4.09±0.38 
4 F4 2.47±0.15 
5 F5 2.22±0.18 
6 F6 2.01±0.09 
 mean±SD, n=3, SD-Standard Deviation. 
 
Test for drug content 
The percentage of drug content in all formulations batches varied 
between the ranges 85.92±1.32 to 95.71±1.42%. Batches with a high 
content of hydrophobic polymers (F4 to F6) showed high drug content 
value. Low SD value in batches indicated that the drug dispersed 
uniformly throughout the polymeric film in each batch. Percentage 
drug content of all formulation batches has given in table 6. 
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Table 6: Test for % drug content in patches 
S. No. Formulation code % Drug content (mean±SD) 
1 F1 85.92±1.32 
2 F2 88.59±1.14 
3 F3 87.51±2.17 
4 F4 94.65±2.42 
5 F5 91.36±2.02 
6 F6 95.71±1.42 
 mean±SD,n=3, SD-Standard Deviation. 
 
Folding endurance 
Folding endurance values have given in table 7. The highest folding 
endurance value was observed for F5 batch and the lowest was 
observed for F1 batch. The high folding endurance value indicates that 
has the high mechanical property of patches [18]. These results indicated 
that the patches would not break under frequent extreme conditions of 
folding and ensured flexibility of formulated transdermal patches. 
 
Table 7: Folding endurance values 
S. No. Formulation code Folding endurance (mean±SD) 
1 F1 76±2.52 
2 F2 87±4.04 
3 F3 85±3.51 
4 F4 98±2.52 
5 F5 101±2.53 
6 F6 94±3.06 
mean±SD, n=3, SD-Standard Deviation 
 
In vitro diffusion studies 
In vitro diffusion study was carried out by using franz diffusion cell and 
egg membrane was used as semi-permeable membrane for diffusion. 
Percentage cumulative drug release was determined for all 6 batches 
and result is shown in table 8 and fig. 5. The percentage cumulative drug 
release was found to be higher for formulation batches F1 to F3 as 
compared to formulation batches F4 to F6. Formulation batches F1 to F3 
gave higher percentage cumulative drug release because they had a 
higher proportion of hydrophilic polymer as compared to formulation 
batches F4 to F6. The same result with hydrophilic polymers is also 
obtained by Hardainiyan et al. [19] and Sadhasivam et al. [20]. High 
polymer content in patches provides faster polymer matrix dissolution 
in aqueous media thus give higher drug release. 
 
 




The transdermal patches were prepared by a solvent casting method 
using a combination of hydrophilic and hydrophobic polymer in 
different ratio. HPMC, PVP, and EC were used as polymer mixtures. 
Propylene glycol and span 80 were used as a plasticizer and 
permeation enhancer, respectively. Total 6 batches (F1to F6) have 
been prepared by using a combination of HPMC, PVP, and EC in 
different ratios. The thickness of the patches varied from 0.33±0.03 
to 0.39±0.01 mm. Formulation batches F1, F2, and F3 have higher 
moisture content and uptake values as compared to other batches 
(F4, F5, F6) due to the presence of higher concentration of 
hydrophilic polymer (HPMC and PVP).  
Folding endurance values of all batches varied from 76±2.52 to 
101±2.53 and drug content were ranged from about 85% to 96%. In 
vitro diffusion studies showed that ratio of hydrophilic and 
hydrophobic polymer in formulation effects the drug release 
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characteristics of patches. Formulation batches F1, F2, and F3 have 
higher cumulative drug release as compared to formulation batches 
F4, F5 and F6. A higher proportion of hydrophilic polymer (HPMC 
and PVP) in formulation batches F1, F2 and F3, gives higher % drug 
release from patches. Thus, in the formulation of effective and 
optimum transdermal patches, the proportion of hydrophilic and 
hydrophobic polymer have a very important role. 
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